There's a New Obesity King
Eli Lilly is now comfortably ahead of Novo Nordisk in the race to dominate the market for obesity treatments.
Starbucks Baristas Walk Out, Picket in Three Cities in Bid for Contract
Employees of the coffee chain launched a five-day action in Chicago, Los Angeles and Seattle after the union called for a strike.
Novo Nordisk Shares Plunge After New Obesity Shot Disappoints
Shares in the company dived after a new anti-obesity treatment missed expectations in a study, denting its chances of becoming the company's next blockbuster weight loss drug.
Three Big Banks Sued by CFPB Over Zelle Scams
The agency says JPMorgan, Bank of America and Wells Fargo didn't do enough to protect users from fraud.
Netflix Scores Next Two FIFA Women's World Cups
The streaming service will have the exclusive U.S. rights to the 2027 and 2031 tournaments.
Trump Transfers Entire $4 Billion Truth Social Stake to His Revocable Trust
Donald Trump has transferred all 114.75 million of his shares in Trump Media & Technology, Truth Social's parent company, to a revocable trust in his control.
Winnebago posts its first adjusted loss in years, as consumers want cheaper RVs
Winnebago's stock falls after another disappointing quarterly report, which included a surprise adjusted loss and a revenue miss.
Carnival Stock Jumps After Earnings. Why It's Cruising Into 2025.
The travel stock looks set to chart a smooth course for the coming year. Management said it expects net income to rise 20% in 2025.
EU Approves Nvidia's Run:ai Takeover
Nvidia's takeover of Israeli streamlining provider Run:ai cleared a key regulatory hurdle with EU approval without conditions.
Synopsys' Bid for Ansys Faces In-Depth Probe in U.K.
The U.K. Competition and Markets Authority said it would launch an in-depth probe into Synopsys' $35 billion acquisition of Ansys, unless the chip-sector companies can offer a deal that eases the regulator's concerns.
(END) Dow Jones Newswires
December 20, 2024 15:00 ET (20:00 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments